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Cell penetrating peptides (CPPs) are attracting attention because of their ability to deliver
biologically active molecules into cells. On their way they can interact with membrane and
intracellular proteins. To fully understand and improve CPP efﬁciency as drug delivery tools,
their  partners need to be identiﬁed. To investigate CPP-protein complexes, chemical cross-
linking coupled to mass spectrometry is a relevant method. With this aim, we  developed an
original approach based on two parallel strategies, an intact complex analysis and a bottom-
up  one, to have a global characterization of the cross-linked complexes composition as well
as  a detailed mapping of the interaction zones.
Biological signiﬁcance: The robust and efﬁcient cross-linking-MS workﬂow presented here can
easily be adapted to any CPP-protein interacting system and could thus contribute to a better
understanding of CPPs activity as cell-speciﬁc drug delivery tools. We  validated the relevancy
of  this cross-linking-MS approach with two biologically active CPPs, (R/W)9 and (R/W)16, and
two  interacting protein partners, actin and albumin, previously reported using isothermal
titration calorimetry (ITC) and NMR. Cross-linking-MS results obtained on these previous
studies allowed us to go further by providing a detailed mapping of the interaction zones.
The  identiﬁed interaction zones between actin and CPPs (R/W)9 and (R/W)16 are biologically
meaningful. Two cross-linked zones [46–57] and [202–210] of actin are indeed involved in
the  modulation of its dynamics. Moreover, [46–57] domain has also been described as oneinteraction domain for thymosin 4 whose actin binding can be displaced by competition
with (R/W)16 (NMR experiments).
© 2014 The Authors. Published by Elsevier B.V. on behalf of European Proteomics
 (EuPAssociation∗ Corresponding author at: Laboratoire des Biomolécules, UMR7203 UP
asse  et protéomique, IBPS-UPMC, France. Tel.: +33 144273234.
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1.  Introduction
Twenty years ago, the discovery of peptides able to ubiq-
uitously cross cellular membranes commonly named cell
penetrating peptides (CPPs), with very limited toxicity,
launched a novel ﬁeld in molecular delivery based on these
non-invasive vectors. Most CPPs are positively charged pep-
tides though the presence of few anionic or hydrophobic CPPs
was also demonstrated. After a decade of debate on the traf-
ﬁcking routes of CPPs to the heart of cells, it is now more
or less accepted that these peptides use concomitantly dif-
ferent internalization pathways, including pinocytosis and
direct membrane translocation processes [1]. CPPs are gener-
ally considered as biologically inert intracellular delivery tools.
However, some CPPs have intrinsically biological activity and
are part of a recently described class of CPPs baptized biopor-
tide [2].
For instance, previous studies showed, that only the two
CPPs (R/W)9 and (R/W)16 (RRWWRRWRR and RRWRRWWR-
RWWRRWRR respectively) among other CPPs tested, are able
to remodel the actin cytoskeleton in oncogen transformed
NIH3T3/EWS-Fli cells once these CPPs had crossed the plasma-
membrane [3]. In order to explain the actin-remodeling
activity of the two  CPPs, the hypothesis of a direct interac-
tion with actin was tested. (R/W)9 and (R/W)16 peptides were
actually found to directly interact in vitro with G-actin by NMR
and ITC experiments [3] (Kd ≈ 10 M and Kd = 0.4 M,  respec-
tively). In addition, competitive binding experiments by NMR
showed that (R/W)16 was able to displace the actin sequester-
ing protein thymosin 4 from G-actin [3].
It was also recently reported that arginine-rich CPPs inter-
act with serum proteins like albumin, modifying their ability
to internalize in cells [4]. Therefore our aim in this study was
to analyze further the interaction of (R/W)9 and (R/W)16 with
actin and albumin.
For this purpose, chemical cross-linking was chosen. Cross-
linking reactions are conventionally based on the use of
a bifunctional cross-linker, which is a carbon chain spacer
bearing reactive sites at both ends that can either be
identical (homobifunctional) or different (heterobifunctional).
Reactive sites are mainly activated esters targeting either
lysine residues (e.g. N-hydroxysuccinimide (NHS) ester) or
cysteine residues (e.g. maleimide ester) although side reac-
tions with tyrosine, threonine and serine have been reported
[5].
By creating a covalent bond between two or more  inter-
acting partners, chemical cross-linking gives a snapshot of a
molecule’s environment and, combined with MS, constitutes
a powerful tool to map  protein-protein or peptide–protein
interactions (distance constraints and interacting domains).
However chemical cross-linking is often characterized by low
reaction yields. In addition, a wide variety of cross-linked
products are usually created. Therefore, cross-linkers bear-
ing an afﬁnity tag [6,7] allowing selective enrichment of the
sample in cross-linked species have been developed. Cleav-
able cross-linkers [8,9], isotope labeled cross-linkers [10] or
cross-linkers bearing a CHCA matrix moiety for MALDI analy-
sis [11] improve detection and identiﬁcation/characterization
of the cross-linked species. Afﬁnity puriﬁcation using a 3 ( 2 0 1 4 ) 229–238
tagged cross-linker or interacting partners [12] and SDS-
PAGE are the most commonly used off-line techniques but
chromatographic methods like strong cation-exchange (SCX)
[13,14] and size exclusion chromatography (SEC) [15] consti-
tute promising approaches to enrich samples in cross-linked
species.
Analysis of low abundant cross-linked peptides requires
high sensitivity for their detection and high mass accuracy
(mass error < 10 ppm) for their identiﬁcation since the num-
ber of combination of two peptides is enormous. Moreover
tandem MS  of cross-linked peptides is required for the char-
acterization of the interaction zones.
A number of tailored softwares have been developed to
deal with the selective acquisition or interpretation of these
MS/MS spectra. Among others, FINDX [16] has been designed
to selectively fragment inter-protein cross-links by LC–MALDI-
TOF/TOF using 14N/15N mixed isotope strategy, xQuest [13]
is dedicated to the search of isotopically tagged cross-linked
peptides and CrossWork [17] or Xlink-Identiﬁer [18] support
label-free analyses of chemical cross-linking samples.
In this study, we set-up a general in vitro analytical workﬂow
coupling cross-linking and mass spectrometry (cross-linking-
MS), involving enrichment steps as well as manual or
automated MS and MS/MS data processing to test potential
interacting partners of any CPP sequence.
To validate our cross-linking-MS workﬂow, we  studied the
systems described above: (R/W)9 or (R/W)16 interacting with
actin or albumin. For this purpose, CPP analogs suitable for
chemical cross-linking experiments, were synthesized with
the following sequences: Biot(O2)-G4-K-RRWWRRWRR-NH2
and Biot(O2)-G4-K-RRWRRWWRRWWRRWRR-NH2, respec-
tively. The K residue added at the N-terminus of the peptides
sequences allowed the cross-linking reaction, the biotin
tag (Biot(O2)) was added for puriﬁcation purpose and was
separated from the biologically active motif by a four G
residues spacer. This {Biot(O)2-Gn-K-} group is easy to add at
the N-terminus of peptides either manually or automatically
during peptide synthesis whatever the peptide sequence.
The originality of our approach resides in the compre-
hensive study of the cross-linking reaction mixture from
two angles: a global view of the interacting system with an
intact complex analysis combined to the precise character-
ization of interacting zones by a bottom-up analysis. The
intact complex analysis is based on the MALDI-TOF anal-
ysis in linear mode of the cross-linking reaction mixtures
and on the modeling of the spectra obtained using the in-
house SIMUL-XL program. The bottom-up analysis consists
in the tryptic digestion of the cross-linking reaction mix-
tures followed by the afﬁnity puriﬁcation (biotin/streptavidin)
of the biotinylated cross-linked peptides and their analysis
by tandem MS (MALDI-TOF/TOF and/or nanoLC–ESI-Orbitrap).
The MS/MS data are either manually interpreted with the
help of GPMAW software [19] (MALDI-TOF/TOF spectra) or
automatically searched using Xlink-Identiﬁer software [18]
(nanoLC–ESI-MS/MS spectra).
For practical reasons the intact complex analysis was
developed only with (R/W)9 and both actin and albumin pro-
teins. In contrast, the bottom-up analysis was performed
using both (R/W)9 and (R/W)16 and both actin and albumin
proteins.
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.  Experimental
.1.  Materials
ovin serum albumin and actin from rabbit muscle were
urchased from Sigma (St. Louis, Missouri, USA). Promix 1,
roteins standard mixture, was from LaserBio Labs (Sophia
ntipolis, France). Bis[sulfosuccinimidyl] suberate (BS3)
as from Thermo Scientiﬁc (Waltham Massachussetts,
SA) and the K100 stabilization kit from CovalX (mix of
hree cross-linkers 1,1′-(suberoyldioxy)bisazabenzotriazole
SBAT), 1,1′-(suberoyldioxy)bisbenzotriazole (SBBT) and
,1′-(glutaroyldioxy)bisazabenzotriazole (GBAT)) (Schlieren,
witzerland). Trypsin Gold, Mass spectrometry Grade, was
rom Promega (Fitchburg, Wisconsin, USA). Dynabeads
280 streptavidin-coated magnetic beads were from Invi-
rogen (Carlsbad, New-Mexico, USA). The CPPs (R/W)9:
iot(O2)-G4-K-RRWWRRWRR-NH2 (m/z 2127.12) and (R/W)16:
iot(O2)-G4-K-RRWRRWWRRWWRRWRR-NH2 (m/z 3309.76)
ere synthesized (Fmoc strategy) and puriﬁed in-house.
iptip® C4 pipette tips were from Millipore (Darmstadt,
ermany).
.2.  Cross-linking  reactions
onomeric actin (G-actin) purchased lyophilized in Tris, ATP,
nd CaCl2 was dialysed against a 20 mM HEPES, 150 mM NaCl,
.5 mM DTT, 200 M CaCl2, 200 M ATP and 0.005% NaN3
H 8 buffer (Actin non-denaturing buffer). Stock solutions
f CPP and actin were diluted in the actin non-denaturing
uffer to obtain the desired concentrations (typically 10 M).
or CPP and albumin a 20 mM HEPES, 150 mM NaCl buffer
as used. For all experiments, after 15 min  pre-incubation
f the CPP and protein partners, 50 mM cross-linkers solu-
ions prepared extemporanely in dimethylformamide (DMF) for
he K100 kit, in water for BS3, were added to have a 2 mM
nal concentration of cross-linkers (200 folds higher than
roteins concentration) and the reactions were allowed to
roceed for 120 min  at room temperature (RT) under gen-
le stirring. Typical cross-linking reactions (XL) volumes were
0 L. For experiments with low peptides concentrations (1 or
.1 M),  reaction volumes were adapted (200 L and 2000 L
espectively) to allow purifying enough cross-linked peptides.
ontrol reaction mixtures noted CT were performed in the
ame conditions but without cross-linkers. Cross-linking reac-
ions were quenched by adding Tris-base (ﬁnal concentration
5 mM).
.3.  Enzymatic  trypsin  digestion
5 L of samples were submitted to in-solution tryptic diges-
ion. Disulﬁde bridges were reduced (5 mM dithiothreitol) and
ysteines alkylated (20 mM iodoacetamide). Trypsin digestion
as conducted at 37 ◦C overnight (1:30 (w:w) protease-to-
rotein ratio). ( 2 0 1 4 ) 229–238 231
2.4.  Biotinylated  cross-linked  peptides  afﬁnity
puriﬁcation
A volume of tryptic digest corresponding to 80 pmol of CPP was
incubated with 200 g of streptavidin-coated magnetic beads
for 60 min  at RT under gentle stirring. Beads were conditioned
before use and washed after incubation [12]. Finally, peptides
were eluted from the beads with 5 L 0.1 M hydrochloric acid
(HCl) under gentle stirring (30 min).
2.5.  MS  analysis  and  data  treatment
MALDI-TOF spectra were obtained with a MALDI-TOF/TOF
AB4700 Proteomics Analyzer mass spectrometer (Applied
Biosystems) in positive ions linear or reﬂector mode and
delayed extraction. CHCA (Sigma) was used as the matrix and
solubilized at 5 mg/mL  in 1/1 ACN/0.1% TFA.
Intact complexes analysis in linear mode MALDI-TOF: 0.5 L of
non-digested reaction mixtures puriﬁed by C4 Ziptip® were
mixed with an equal volume of matrix and deposited on the
sample holder. A total of 20,000 laser shots per sample were
acquired in the m/z range 10,000–100,000 (focus mass 60,000).
Modelings of the spectra obtained for intact cross-linked
complexes and corresponding controls were achieved using
SIMUL-XL, a program developed in-house (Visual Basic V6.0).
Bottom-up analysis in reﬂector mode MALDI-TOF/TOF: After
afﬁnity puriﬁcation, 0.5 L of the elution mixture was mixed
with 0.5 L matrix and 0.5 L were deposited on the sample
holder. A total of 10,000 laser shots per spot were acquired
in the m/z range 500–5000. External calibrations were real-
ized using the peptide calibration standard Pepmix4 (Laser
BioLabs). A manual interpretation of the spectra was done
comparing the cross-linking reaction mixture (XL) and the
peptide and protein mixture without cross-linker (CT) spectra.
Differential peaks identiﬁed in XL spectrum were confronted
with the cross-linked peptides lists generated in silico using
General Protein Mass Analysis for Windows (GPMAW) version
6.1 [19] (Lighthouse Data, Odense, Denmark) with a number of
missed-cleavages for trypsin of 2.
NanoLC–ESI-Orbitrap: The complete characterization of the
cross-linked peptides was performed using an Ultimate 3000
Nano-HPLC system (Dionex) coupled with a LTQ-Orbitrap-XL
mass spectrometer (Thermo Scientiﬁc). Samples were injected
by the autosampler and concentrated on a trapping column
(Pepmap, C18, 300 m × 5 mm,  5 m,  100 A˚, Dionex) with water
containing 2% ACN and 0.1% formic acid (solvent A). After
10 min, the peptides were eluted onto the separation column
(Pepmap, C18, 75 m × 150 mm,  2 m 100 A˚, Dionex) equili-
brated with 98% solvent A. Peptides were separated using the
gradient 0–50 min  2–40% solvent B (98% ACN + 0.1% formic
acid), 50–60 min  40–60% solvent B, and 60–70 min  60% sol-
vent B at a ﬂow rate of 200 nL/min. The LTQ-Orbitrap mass
spectrometer is outﬁtted with a nano ESI interface. Electro-
spray emitters were 360/20 m o.d. × 10 m i.d. fused-silica
tips (PicoTip Emitter, Standard Coated SilicaTip, New Objec-
tive). The heated capillary temperature and spray voltage were
200 ◦C and 1.5 kV, respectively. Orbitrap spectra (automated
gain control (AGC) 2 × 105) were collected from m/z  300–2000
at a resolution of 30,000 in the proﬁle mode followed by data
dependent sequential CID and HCD MS/MS spectra of the three
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Fig. 1 – General analytical workﬂow to in vitro identify and characterize protein partner(s) of a known CPP. The chemical
cross-linking reaction between a biotinylated CPP, the BS3 cross-linker and a potential protein partner is presented (top
ing ascheme). The cross-linked complexes were characterized us
most intense ions with a normalized energy of 35 for both frag-
mentation modes. A dynamic exclusion time of 60 s was used
to discriminate against previously analyzed ions.
MS/MS  spectra were automatically searched using the
Xlink-Identiﬁer software [18]. Xlink-Identiﬁer is a search
engine for identifying and characterizing cross-linked pep-
tides from label-free experiments (neither the peptide nor
the cross-linker is isotopically labeled). It takes the MS/MS
spectra in .dta or .mgf format and the protein sequences in
FASTA format. Search parameters include the fragmentation
technique, the nature of the dynamic modiﬁcations (car-
bamidomethylation (C), oxidation (M)), the maximum number
of missed-cleavages, the precursor and fragment mass toler-
ance (respectively 10 ppm and 0.6 Da) and ﬁnally the deﬁnition
of the cross-linker spacer arm mass involved in the formation
of the cross-linking products (96.0211 Da for GBAT, 138.0618 Da
for SBAT, SBBT or BS3).
As mentioned, Xlink-Identiﬁer is a fully automated search
engine speciﬁcally for cross-linking analysis. It is equipped
with a visualization module allowing researchers to exam-
ine the annotated MS/MS  spectra and details of each matched
peak.3.  Results  and  discussion
In this study, we  synthesized analogs of (R/W)9 and
(R/W)16 CPPs (Biot(O2)-G4-K-RRWWRRWRR-NH2 andn intact complex analysis (A) and a bottom-up one (B).
Biot(O2)-G4-K-RRWRRWWRRWWRRWRR-NH2, respectively)
adapted for cross-linking experiments. To study the interac-
tion of these CPPs with protein partners, a cross-linking-MS
approach integrating two parallel strategies, an intact com-
plex analysis and a bottom-up one, was developed and
optimized (Fig. 1).
3.1.  Chemical  cross-linking  reaction
Actin is a globular 42 kDa protein that binds an ATP molecule
and a divalent cation (Mg2+ or Ca2+). These cofactors are neces-
sary to maintain the integrity of the protein. Commercial actin
was available as a lyophilized powder containing Tris buffer,
which is not compatible with chemical cross-linking because
of its reactive primary amine group. The sample was thus
dialysed against an HEPES buffer also containing appropriate
concentrations of salts and actin cofactors. Initial concentra-
tion of 10 M was chosen for the two partners as the speciﬁcity
of chemical cross-linking with activated esters was demon-
strated in the low M range [20].
We worked with a mixture of three cross-linkers (K100
stabilizing kit): SBAT, SBBT and GBAT (Fig. S-1). This mix-
ture of cross-linkers is recommended to stabilize complexes
with a molecular weight below 100 kDa and allows testing two
spacer lengths at the same time (11.4 A˚  for SBAT and SBBT and
7.7 A˚ for GBAT). The K100 kit cross-linkers were solubilized in
DMF. To make sure that the small proportion of this organic
e u  p a o p e n p r o t e o m i c s 3 ( 2 0 1 4 ) 229–238 233
Fig. 2 – Positive ions linear mode MALDI-TOF of intact controls and chemical cross-linking reaction mixture. The controls
(REF, CL and CT) are presented on the three top spectra, the cross-linking experiment (XL) in the lower spectrum. Mass
spectra were  modeled using SIMUL-XL program. Modelings (black) that best ﬁt the experimental data (gray) are presented in
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olvent is not affecting the protein or peptide conformation
nd their interactions and thus the cross-linking reactions
esults, experiments were repeated with the BS3 water sol-
ble cross-linker which has the same spacer arm as SBAT or
BBT.
Supplementary Fig. 1 can be found, in the online version,
t doi:10.1016/j.euprot.2014.03.002.
.2.  Intact  complex  analysis:  determination  of  (R/W)9
PP  –  protein  ratio  in  intact  cross-linked  complexes
inear mode MALDI-TOF: MALDI-TOF is usually not a method
f choice to study non-covalent complexes due to imperfect
reservation of complexes during target preparation and
nspeciﬁc non-covalent multimers desorption due to spatial
roximity and high concentration in the matrix crystals.
owever it is well adapted to the study of covalent complexesormed using chemical cross-linking. Linear mode MALDI-
OF analyses of the intact complexes were carried out after
 simple desalting step of the samples on a C4 ZipTip®. The
im was to assess the efﬁciency of the cross-linking reaction number of (R/W)9, 〈N〉: average number of cross-linker.
by determining the average number of (R/W)9 CPPs covalently
attached per protein, for different reaction conditions.
To assess the contribution of the different components to
the observed signal for a cross-linking reaction (XL), controls
are necessary: the protein alone (REF), the protein plus the
cross-linker only (CL) (to assess the mono-links, intra and inter
cross-linked proteins), and the (R/W)9 CPP and the protein
mixture without the cross-linker (CT) (to assess non-covalent
interactions that could remain even with the acidic CHCA dis-
sociative matrix). Many precautions need to be taken in the
preparation of these controls and in mass spectra acquisi-
tion (same laser ﬂuence and focus mass as for XL mixture).
To quantitatively describe the different mass spectra obtained
(number of mono-links, number of peptides covalently or
non-covalently attached) a dedicated program SlMUL-XL was
developed in our laboratory (Visual Basic V6.0) and is available
as an open source on request at gerard.bolbach@upmc.fr.
Modeling of intact interacting species:  The modeling is based
on the experimental peak proﬁle of the protein alone (singly
and multiply charged ions) (REF spectrum, Fig. 2). To each point
of this proﬁle a hypothetical distribution of (R/W)9 or mono-
links or (R/W)9 + mono-links is added. The average number of
 m i c s
at doi:10.1016/j.euprot.2014.03.002.234  e u  p a o p e n p r o t e o
mono-links is noted 〈N〉 and of (R/W)9 CPPs is . Mono-links for
which the average number is much greater than one are added
according to a gaussian law with a chosen standard deviation
value , while (R/W)9 CPPs are added according to a poisson
law since the average number  is less than one.
The ﬁnal peak proﬁle is build up by superimposition of
all these proﬁles (Fig. S-2). The comparison of this convo-
luted proﬁle with the experimental data allows adjusting
the hypothetical distribution of (R/W)9 or cross-linkers or
(R/W)9 + cross-linkers. The initial proﬁle of the protein alone
is large including the isotopic pattern, initial axial velocity
effects and matrix adducts. In comparison, the isotopic pat-
tern of the (R/W)9 peptide and of the cross-linker are negligible
and they are thus not taken into account. Simple gaussian
and Poisson distributions were found to ﬁt satisfactory the
experimental data.
Supplementary Fig. 2 can be found, in the online version,
at doi:10.1016/j.euprot.2014.03.002.
This work was performed for both interacting systems,
(R/W)9-albumin and (R/W)9-actin, for two ratios 1:1 and 6:1.
The 1:1 ratio is giving us an indication on the cross-linking
reaction “yield” and the 1:6 ratio (large excess of peptide) was
chosen to see if the CPP could have more  than one interac-
tion sites on the proteins. Spectra and modelings obtained
for the (R/W)9-albumin system in a 1:1 ratio are presented in
Fig. 2.
The CL mixture was satisfactory ﬁtted with a gaussian dis-
tribution of cross-linkers centered on 〈N = 49〉  with  = 5. This
suggests a very good accessibility of the lysine residues (total
52). The same distribution was found to ﬁt all the charge states
demonstrating that the covalent attachment is the major
interaction and that non-covalent attachments are negligible
[21] even in the presence of a large excess of cross-linkers.
The XL mixture spectrum was correctly ﬁtted for all the
charge states (+1 to +4) using the previous cross-linker gauss-
ian distribution (〈N = 49〉  and  = 5) and a Poisson distribution
of (R/W)9 CPP with a mean value of  = 0.95. Increasing the ratio
(R/W)9-albumin to 6:1, the mean value is  = 3 indicating the
existence of several binding sites on the albumin protein (Fig.
S-3).
Supplementary Fig. 3 can be found, in the online version,
at doi:10.1016/j.euprot.2014.03.002.
For CT samples, we  observed that peaks can be ﬁtted with a
CPP Poisson distribution with a mean value strongly depend-
ent on the charge state: 0.7 for +1 and 0.5 for +3. Similar results
were found with both CPPs–protein ratios 1:1 and 6:1. This
observation is in good agreement with in-source dissociation
of the non-covalent complexes in MALDI-TOF [21].
All these results clearly show that a high cross-linking yield
is observed for the (R/W)9-albumin interacting system and
that artifacts due to non-covalent interactions, if any, are neg-
ligible for XL reaction mixture.
For the (R/W)9-actin interacting system in a 1:1 ratio, CL was
ﬁtted with 〈N = 8〉 mono-links and  = 2, indicating that some
of the 17 lysines are likely less exposed than others to the
cross-linkers. The best ﬁt for the XL mixture was obtained with
〈N = 6〉 mono-links and  = 0.3 CPP (data not shown). Hence the
cross-linking yield was low for the (R/W)9-actin system. For a
6:1 ratio, the S/N was too low and mass spectra were thus not
interpreted using SIMUL-XL program. 3 ( 2 0 1 4 ) 229–238
The results of this strategy devoted to intact complexes
show an in vitro direct interaction of (R/W)9 CPP with both albu-
min  and actin. It also easily gives access to the efﬁciency of
the cross-linking reaction, by providing an estimation of the
average number of accessible lysine residues and covalently
attached CPPs. Cross-linked complexes obtained with a rela-
tively high yield could correspond to a rather homogeneous
or heterogeneous population. This was further studied using
the bottom-up analysis.
3.3.  Bottom-up  analysis:  characterization  of  the
interacting  zones  between  (R/W)9 or  (R/W)16 CPPs  and
actin or  albumin  proteins
MALDI-TOF analysis of the puriﬁed cross-linking digests
revealed a robust, reproducible and efﬁcient method to eval-
uate and optimize the cross-linking experiments workﬂow
(evaluation of the efﬁciency of the afﬁnity puriﬁcation step,
the speciﬁcity of the cross-linking reactions, the inﬂuence of
the CPP to protein ratio etc.).
Puriﬁcation of the biotinylated tryptic cross-linked peptides.
Among the possible products of the cross-linking reactions,
we had to distinguish between the mono-linked species on
one of the partner (CPP or protein) of the complex, the intra-
or inter-protein cross-linked products and the cross-linked
products involving both the CPP and the protein, the latter
being those of interest. After in-solution trypsin digestion of
the cross-linking (XL) and control (CT) mixtures, species con-
taining the tryptic biotinylated CPP were selectively enriched
through a biotin/streptavidin afﬁnity puriﬁcation step using
streptavidin-coated magnetic beads. An improvement of the
initial protocol [12] was achieved by adding a 10 min  incuba-
tion step of the beads in 100% ACN to remove non-speciﬁcally
adsorbed species. The elution step was also adapted to the
cross-linking-MS workﬂow to allow the elution of the cross-
linking products in an aqueous phase compatible with the
nanoLC–MS/MS system. Three different acidic elution solu-
tions were compared: 0.1% TFA, 10% formic acid (FA) and 0.1 M
HCl, the latter turned to be the most efﬁcient. MALDI-TOF
analysis of the streptavidin beads directly spotted onto the
sample holder after treatment with 0.1 M HCl revealed that the
great majority or even the totality of the cross-linked species
were released from the beads.
Fig. S-4 emphasizes the absolute necessity of a puriﬁ-
cation/enrichment step for the observation of subpicomole
cross-linked products. Moreover this enrichment is highly
selective as the MALDI-TOF analysis of the puriﬁed sam-
ples showed only few hydrophobic albumin tryptic peptides
non-speciﬁcally adsorbed on the beads. It is important to
notice that biotin/streptavidin afﬁnity puriﬁcation performed
on intact complexes prior to trypsin digestion revealed unsuc-
cessful. In this case, the recognition of the biotin tag by the
streptavidin molecules is likely hindered when the CPPs (2.1
or 3.3 kDa) are associated to a bulky protein (42 kDa  for actin
and 66 kDa for albumin).
Supplementary Fig. 4 can be found, in the online version,Manual bottom-up MALDI-TOF data analysis. For XL exper-
iments of both CPP-actin and CPP-albumin interacting
systems, a visual comparison of the MALDI-TOF spectra of
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Fig. 3 – Positive ions reﬂector mode MALDI-TOF of reaction mixtures after biotin/streptavidin afﬁnity puriﬁcation for
actin-(R/W)9 and albumin-(R/W)9 interacting systems. XL stands for cross-linking experiments with actin or albumin (A1,
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t1), CT are the corresponding controls without cross-linking
L and CT reactions, allowed to identify discriminating peaks
ppearing only in the XL reaction. Fig. 3 shows XL and CT
ALDI spectra obtained for the (R/W)9 CPP-actin or (R/W)9
PP-albumin systems. Same peaks were obtained with the
R/W)16 CPP corresponding systems.
The manual confrontation of this list of discriminating
eaks with the GPMAW list of predicted cross-links led to the
dentiﬁcation of cross-linked peptides (Table 1). Sequences of
ross-linked peptides are presented in Table S-1.
Supplementary Table S-1 can be found, in the online ver-
ion, at doi:10.1016/j.euprot.2014.03.002.
As external calibration of each spectrum was realized on
he nearest position, the cross-linked peptides were identiﬁed
ith a very satisfying mass accuracy (<20 ppm) providing a
ood conﬁdence in the results. For the (R/W)9 or (R/W)16-actin
nteracting system a total of nine cross-linked peptides were
eproducibly (ﬁve independent experiments) identiﬁed, which
orrespond to four different zones (six lysines) of the protein
nd for (R/W)9 or (R/W)16-albumin, eight cross-linked peptides
ere identiﬁed as ﬁve different zones (seven lysines) of the
rotein.
Speciﬁcity of the cross-linking reaction: To look at the speci-
city of the reaction, we  achieved a competition experiment
ith both actin and albumin. Therefore, 10 M of (R/W)9 CPP
ere incubated with 10 M of each protein and 2 mM of BS3
ross-linker. The MALDI-TOF spectra of the puriﬁed digests
howed peaks corresponding to cross-linked peptides with
ctin and with albumin. Even if the intensity of the peaks could
ot be directly related to their abundance in MS,  the close
elative intensity of the peaks corresponding to cross-linked
eptides with both proteins, strongly suggested that associa-
ion constants of (R/W)9 CPP for actin and albumin were within
he same range of values.nts (A2, B2).
The speciﬁcity of the cross-linking reaction was also
checked by incubating (R/W)9 CPP (10 M)  with Promix1,
a commercial mixture of three proteins: insulin (4 M),
cytochrome C (12 M) and myoglobin (16 M)  in the presence
of the K100 kit of cross-linkers. The comparison of the MALDI-
TOF spectra (reﬂector positive ions mode) of the cross-linking
(XL) and control (CT) puriﬁed digests revealed no discrimi-
nating peaks. This is in good agreement with the absence
of formation of complexes between (R/W)9 CPP and these
proteins, that was observed with the intact complex analy-
sis (Fig. S-5). Actually, these three proteins insulin (pI = 7.6),
cytochrome C (pI = 9.6) and myoglobin (pI = 7.2) have either
neutral or basic pI whereas actin (pI = 5.2) and albumin (pI = 5.8)
both have acidic pI (UniprotKB database/ProtParam tool pI val-
ues). Therefore interactions between actin/albumin and the
polycationic (R/W)9 or (R/W)16 CPPs are likely electrostatic, at
least partly.
Supplementary Fig. 5 can be found, in the online version,
at doi:10.1016/j.euprot.2014.03.002.
MALDI-TOF/TOF characterization of the cross-linked peptides.
MALDI-TOF/TOF fragmentation of these ions gave mostly
weak intensity and poor quality spectra. However in most
spectra, identical series of peaks at m/z 259.1, 316.1, 373.1,
430.1 were observed corresponding to the N-terminal ions of
the biotinylated tag added to the CPPs sequences (Biot(O2),
Biot(O2)-G, Biot(O2)-GG and Biot(O2)-GGG respectively). This
fragmentation highly competes with the formation of other
fragments, which partly explains the poor quality of the high
collision energy MS/MS spectra. However, the formation of
these diagnostic ions constitutes a relevant marker of the pres-
ence of the biotinylated CPP in the cross-linked species.
The limited number of fragments obtained by MALDI-
TOF/TOF did not allow characterization of the branched
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Table 1 – Manual interpretation of cross-linked peptides between (R/W)9 and actin (A) or albumin (B) using GPMAW
software. Experimental versus simulated m/z values of identiﬁed cross-linked peptides between (R/W)9 and actin or
albumin obtained after trypsin digestion are presented in the two left columns. The delta mass is in the third column.
Corresponding tryptic peptides of the protein and (R/W)9 are in the two last columns. Sequences of the cross-linked
peptides underlined were  conﬁrmed by MS/MS. Same results were  obtained with (R/W)16.
Exp. m/z  of
potential
cross-linked
peptides
Theo. m/z value
(GPMAW)
 mass (ppm) Potential tryptic
peptides involved
in the complex
Potential tryptic
(R/W)9 involved in
the complex
A. Actin-(R/W)9 interacting system
1963.067 1963.079 6.1 322–332 1–7
2056.065 2056.086 10.2 202–210 1–7
2091.153 2091.174 10.0 322–333 1–7
2124.952 2124.95 0.9 46–57 1–6
2281.035 2281.051 7.0 46–57 1–7
2329.208 2329.225 7.3 311–323 1–7
2475.201 2475.24 15.7 308–321 1–7
3223.61 3223.653 13.3 91–111 1–7
3277.543 3277.503 12.2 35–56 1–7
3433.56 3433.605 13.1 35–57 1–7
B. Albumin-(R/W)9 interacting system
1743.916 1743.917 0.5 452–459 1–7
1773.943 1773.932 6.2 242–248 1–7
1916.992 1916.986 3.1 210–218 1–7
1928.016 1928.017 0.5 233–241 1–7
2069.158 2069.142 7.7 548–557 1–7
2120.031 2120.03 0.5 24–34 1–6
or 2120.03 0.5 25–34 1–7
2176.058 2176.049 4.1 35–44 1–7
0.0 
0.0 2276.131 2276.131 
or 2276.131 
peptides. Moreover, manual identiﬁcation of cross-linked pep-
tide can be envisaged for simple and well deﬁned interacting
system (e.g. two known partners) but is not suitable for more
complex mixtures. Therefore we developed an online and
automated separation (nanoLC system), data acquisition (ESI-
LTQ-Orbitrap) and data search (Xlink-Identiﬁer) adapted to
more complex systems involving a known biotinylated pep-
tide or protein with one or several unknown partners. This
automated procedure was validated with the same CPPs-
protein (actin or albumin) interacting systems.
NanoLC–ESI-Orbitrap automatic data analysis. NanoLC–ESI-
MS/MS  analyses of the puriﬁed digests were performed in
order to conﬁrm cross-linked peptides sequences. We  noticed
that these analyses of low abundant peptides had to be done
rapidly after afﬁnity puriﬁcation to avoid sample adsorption
on the plastic tubes. If the nanoLC–MS/MS analysis was done
within the 2 days following the puriﬁcation step then the sen-
sitivity of the LTQ-Orbitrap mass spectrometer was adequate
to detect cross-linked peptides and to trigger MS/MS on their
precursor ions.
MS/MS  data treatment via Xlink-Identiﬁer. The MS/MS spectra
generated were searched using Xlink-Identiﬁer [18]. Xlink-
Identiﬁer generates a list of cross-linked peptides for a given
mass tolerance. For our experiments the mass tolerance on
the precursor ions was set at 10 ppm. For each cross-linked
peptides identiﬁed, Xlink-Identiﬁer indicates the position of
the cross-linking sites and provides matching scores includ-
ing XlinkScore and the mass accuracy for the precursor ions
selected (Fig. S-6A and B). A link is also available to visualize
the corresponding MS/MS  spectrum with identiﬁed fragments24–34 1–7
25–34 1–7
from both peptide chains (labeled a or b) and highlighted in
different colors according to their type (b, y etc.).
Supplementary Fig. 6 can be found, in the online version,
at doi:10.1016/j.euprot.2014.03.002.
NanoLC–ESI-MS/MS analysis of the cross-linked peptides
allowed conﬁrming the sequence of 7 out of the 10 cross-linked
peptides previously identiﬁed for the CPPs-actin interacting
systems in MALDI-TOF while all except one cross-linked
peptides sequences were conﬁrmed for the CPPs-albumin
complex. Moreover three additional cross-linked pep-
tides were found for the CPPs-albumin systems searching
NanoLC–ESI-MS/MS data with Xlink-Identiﬁer.
The identiﬁcations were mainly obtained using CID spectra
and conﬁrmed with HCD spectra (Fig. S-7). CID spectra were
generally sufﬁcient to validate the sequences.
Supplementary Fig. 7 can be found, in the online version,
at doi:10.1016/j.euprot.2014.03.002.
All the cross-linked peptides identiﬁed were the result of a
covalent bond formation between the CPPs and actin or albu-
min  via the longer version of the cross-linker (SBAT or SBBT).
The similar results obtained using the BS3 cross-linker showed
that the leaving group type did not seem to modify the number
or the nature of the cross-linked peptides obtained.
The vast majority of the cross-linked species identiﬁed
between the biotinylated CPPs and the protein partner (albu-
min  or actin) contained the biotinylated CPP under the
Biot(O2)-G4-K-R form (residues 1–7) since the covalent link on
the lysine prevents the trypsin cleavage after the K residue.
It is worth noticing that the covalent attachment
of the Biot(O2)-G4-K-R group could be considered as a
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Fig. 4 – X-Ray structure of the complex actin: thymosin 4
(PDB ID) [22]. The actin protein is colored in red, thymosin
4 in green. Interaction zones characterized between the
CPPs (R/W)9 or (R/W)16 and actin [202–210] from
sub-domain 4 and [35–57] from sub-domain 2 are in blue
(the region [40–50] is not visible on the crystal structure
since it has not been crystallized). The lateral chain of the K
residues K56 and K208 of actin, involved in the
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characterize membrane and intracellular partners for theseross-linking are indicated.
ost-translational modiﬁcation of the peptides issued from
he protein digestion and searched in this way with conven-
ional search engine such as Mascot. However, contrary to
link-Identiﬁer, with this type of search we  can only have
S/MS  information on the protein part and scoring of these
ross-linked peptides is not properly made.
Data rationalization in a biological context. Cross-linking
xperiments were repeated several times for each interac-
ing systems, giving reproducible results and leading to the
dentiﬁcation of the same interaction zones for each system.
or (R/W)9 or (R/W)16-actin systems four different interaction
ones were found: [35–57] containing the cross-linked K45 and
56, [91–111] containing the cross-linked K108, [202–210] con-
aining the cross-linked K208 and [308–333] containing the
ross-linked K310, K321 and K323 (Fig. S-8). For (R/W)9 or
R/W)16-albumin interacting systems ﬁve different interaction
ones were identiﬁed: [24–44], [210–218], [233–248], [452–459]
nd [548–557]. In addition, using the protein, actin or albu-
in, in a large excess (10:1 protein:CPP) gave the same results
ndicating that there would not be any preferential interaction
ite among the sites identiﬁed or any order in the colonization
f these sites.
Supplementary Fig. 8 can be found, in the online version,
t doi:10.1016/j.euprot.2014.03.002.
Using PyMOL free software program (DeLano Scientiﬁc
LC), it was possible to localize the identiﬁed interaction zones
n the 3D structure (X-ray crystallography) of the protein for
oth systems. Demonstration of a direct interaction of both
PPs with the serum protein albumin is of interest for in vivo
pplications, since it might affect positively (protect from
egradation) or negatively (sequestration of the CPP) the cell
elivery of conjugated cargoes into cells [4]. This interaction ( 2 0 1 4 ) 229–238 237
could involve electrostatic, hydrophobic or /cation interac-
tions, which could explain the dispersion and multiplicity of
the interaction zones identiﬁed in albumin.
In the case of actin, three out of the four interaction
zones containing the cross-linked lysines K45/K56, K108,
K310/K321/K323, are located on the outer surface of the pro-
tein and are accessible to the CPPs (Fig. S-8). By contrast, the
cross-linked lysine K208 is located in the close proximity of the
nucleotide binding cleft and is less exposed to the solvent. It
was previously reported that both (R/W)16 and (R/W)9 interact
with G-actin [3]. We  identiﬁed in this study identical domains
of interaction for the two CPPs in actin. (R/W)16 was shown
previously to compete with the G-actin sequestering protein
thymosin-ß4 for binding to actin [3]. Interestingly, among
the cross-linked regions identiﬁed in this study, the domains
[35–57] (K45 and K56) and [202–210] (K208) are localized within
the binding domain of thymosin-ß4 [22] (Fig. 4), a spatial prox-
imity that could explain the previous results of competition
experiments. Actin polymerization/depolymerization dynam-
ics is a complex process that involves numerous actin binding
proteins (capping, nucleation, elongation, severing or bundle
proteins). Kang and co-workers recently identiﬁed two dis-
crete cation-binding sites within F-actin that they described
as “polymerization” (driving actin ﬁlament assembly) and
“stiffness” (modulating ﬁlament bending rigidity) sites [23].
Knowing that (R/W)9 and (R/W)16 CPPs can induce formation
of stress ﬁbers in cells that genetically lack F-actin formation,
it is of particular interest to ﬁnd herein that these CPPs bind G-
actin within these two cation-binding regions that have been
described to modulate actin dynamics in cells.
4.  Conclusions
We  set up and optimized a robust and efﬁcient cross-linking-
MS  workﬂow allowing a complete characterization of in vitro
CPP-protein interacting systems. This workﬂow originally
designed for the study of CPP interaction partners can be
applied to various interacting systems composed of two or
more  potential protein partners as soon as one of the two
partners is known and can be labeled for enrichment purpose
(e.g.: biotin tag). While the intact complex analysis gives reli-
able information on the cross-linking reaction yield and the
cross-linked complexes composition according to the reaction
conditions, the bottom-up analysis allows identiﬁcation and
characterization of the interaction zones.
Our study based on (R/W)9 and (R/W)16 CPPs illustrates the
necessity of the use of cross-linking-MS for the in vitro study of
interaction partners, and its complementarity with analytical
techniques such as ITC and NMR.
Other CPPs can now be analyzed using the same strategy, in
particular Tat that was shown to remodel actin cytoskeleton in
actin-encapsulated giant vesicles [24]. Biologically speaking,
we can anticipate that many,  if not all, CPPs are not so inert
and that similar cross-linking-MS strategies will be helpful topeptides. Mapping the domains of interaction by cross-linking
approaches will also help understanding, at least partly, the
biological activity of CPPs.
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